Account
Inquiry
Tirzepatide, also known as LY3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
The product features a high affinity for GIP receptors, mimicking natural GIP actions while providing enhanced hyperglycemia reduction. Tirzepatide has been studied for improving blood sugar control in combination with diet and exercise protocols.
Our Tirzepatide is supplied as a lyophilized powder with 99% purity, ensuring consistent quality for research applications. Proper storage under refrigeration is essential to maintain stability and efficacy throughout the shelf life.
This product is offered in multiple packaging options to accommodate various research needs. All materials are strictly for research use and not intended for human consumption.
